E 34 (Clopidogrel bisulfate 75 mg (base))
Pill imprint E 34 has been identified as Clopidogrel bisulfate 75 mg (base).
Clopidogrel is used in the treatment of ischemic stroke; peripheral arterial disease; ischemic stroke, prophylaxis; heart attack; acute coronary syndrome, prophylaxis (and more), and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Clopidogrel 75 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).
- E 34
- 75 mg (base)
- Prescription only
- Drug Class:
- Platelet aggregation inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Aurobindo Pharma Limited
- National Drug Code (NDC):
- Inactive Ingredients:
hydrogenated castor oil
low substituted hydroxypropyl cellulose
hypromellose 2910 (15 mPa.s)
ferric oxide red
polyethylene glycol 6000
|NDC Code||Manufacturer / Repackager|
|68084-0609||Amerisource Health Services|
Note: Inactive ingredients may vary.
More about clopidogrel
- Other brands: Plavix
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.